Assistant Professor
Oncology
Dr. Vamsidhar Velcheti, MD
|
|
Give Review
Vamsidhar Velcheti works in the field of Oncology. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He has 10 awards "Career Development Award", "Scott Hamilton CARES initiative research award", "ASCO Merit Award", "Outstanding researcher of the year", "Young Investigator", "The Edward D. Frohlich Award", "Resident Researcher of the Year", "Travel Scholarship", "Certificate of Merit and Excellence in design" and "College Blues Award, Student Scientific Society". Vamsidhar Velcheti is a published doctor and has 26 publications published. The lastest was: 'Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An A...' He accepts all Medicare patients.
Publications
- Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An A...
- Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib.
- Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.
- Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
- Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer.
- RET-Rearranged Lung Adenocarcinomas with Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib.
- Coexistent pulmonary granular cell tumor and Adenocarcinoma of the lung.
- In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas.
- Programmed death ligand-1 expression in non-small cell Lung cancer.
- Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1).
- Metastatic Cancer involving bladder: a review.
- Pneumocystis pneumonia in a patient with non-small cell Lung cancer (NSCLC) treated with pemetrexed containing regimen.
- Efficacy of vinorelbine in the second-line setting and beyond in non-small cell Lung cancer.
- The proportion of patients with metastatic non-small cell Lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey.
- Insulin-like growth factor and Lung cancer.
- Hedgehog signaling pathway and Lung cancer.
- Hedgehog signaling is a potent regulator of angiogenesis in small cell Lung cancer.
- Drug delivery and toxicity of adjuvant chemotherapy for non-small cell Lung cancer (NSCLC): Washington University experience.
- Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell Lung cancer (NSCLC).
- Radiation-induced myonecrosis presenting as a subcutaneous mass after combined modality therapy for non-small cell Lung cancer.
- Vaginal masses: magnetic resonance imaging features with pathologic correlation.
- Absence of mutations in the epidermal growth factor receptor (EGFR) kinase domain in patients with mesothelioma.
- Management of patients with advanced non-small cell Lung cancer: role of gefitinib.
- Pathogenesis of prostate Cancer: lessons from basic research.
- High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas.
Schools
Ochsner Med Ctr
Yale New Haven Hsop
Procedures Preformed
- Genomic Testing
- Immunotherapy
- Thoracentesis
Conditions Treated
- Adenocarcinoma of Lung
- Adult Small Cell Lung Cancer
- Anemia
- Carcinoid Tumor
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- Career Development Award
- Scott Hamilton CARES initiative research award
- ASCO Merit Award
- Outstanding researcher of the year
- Young Investigator
- The Edward D. Frohlich Award
- Resident Researcher of the Year
- Travel Scholarship
- Certificate of Merit and Excellence in design
- College Blues Award, Student Scientific Society
Education
-
Yale University School of Medicine -
Ochsner Clinic Foundation -
Armed Forces Medical College Pune
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1477744316 | |
| NPPES Provider LastName | VELCHETI | |
| NPPES Provider FirstName | VAMSIDHAR | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 15.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477744316 |
| Last Name Of The Provider | VELCHETI |
| First Name Of The Provider | VAMSIDHAR |
| View All |
Similar Doctors
|
|
Dr. Lindsey M. Goodman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Paolo F. Caimi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alberto J. Montero, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Donald Eicher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alok A. Khorana, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Erica L. Campagnaro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernest C. Borden, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Dragana Tomic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debora S. Bruno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yael Hegerfeldt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Cheng E. Chee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aparna Kalyan, MD |
|
|
Dr. Maissaa Janbain, MD
This Doctor is OpenDoctor Recommended.
|